rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6626
|
pubmed:dateCreated |
1997-5-5
|
pubmed:abstractText |
How DNA damage is converted into intracellular signals that can control cell behaviour is unknown. The c-Abl protein tyrosine kinase is activated by ionizing radiation and certain other DNA-damaging agents, whereas the DNA-dependent protein kinase (DNA-PK), consisting of a serine/threonine kinase and Ku DNA-binding subunits, requires DNA double-strand breaks or other DNA lesions for activation. Here we demonstrate that c-Abl interacts constitutively with DNA-PK. Ionizing radiation stimulates binding of c-Abl to DNA-PK and induces an association of c-Abl with Ku antigen. We show that DNA-PK phosphorylates and activates c-Abl in vitro. Cells deficient in DNA-PK are defective in c-Abl activation induced by ionizing radiation. In a potential feedback mechanism, c-Abl phosphorylates DNA-PK, but not Ku, in vitro. Phosphorylation of DNA-PK by c-Abl inhibits the ability of DNA-PK to form a complex with DNA. We also show that treatment of cells with ionizing radiation results in phosphorylation of DNA-PK that is dependent on c-Abl. Our results support the hypothesis that there are functional interactions between c-Abl and DNA-PK in the response to DNA damage.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Nuclear,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Helicases,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Activated Protein Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ku autoantigen,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-abl,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine,
http://linkedlifedata.com/resource/pubmed/chemical/XRCC5 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0028-0836
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
386
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
732-5
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:9109492-Animals,
pubmed-meshheading:9109492-Antigens, Nuclear,
pubmed-meshheading:9109492-Cell Line,
pubmed-meshheading:9109492-DNA Damage,
pubmed-meshheading:9109492-DNA Helicases,
pubmed-meshheading:9109492-DNA-Activated Protein Kinase,
pubmed-meshheading:9109492-DNA-Binding Proteins,
pubmed-meshheading:9109492-Enzyme Activation,
pubmed-meshheading:9109492-Mice,
pubmed-meshheading:9109492-Nuclear Proteins,
pubmed-meshheading:9109492-Phosphorylation,
pubmed-meshheading:9109492-Protein Binding,
pubmed-meshheading:9109492-Protein-Serine-Threonine Kinases,
pubmed-meshheading:9109492-Proto-Oncogene Proteins c-abl,
pubmed-meshheading:9109492-Tyrosine,
pubmed-meshheading:9109492-src Homology Domains
|
pubmed:year |
1997
|
pubmed:articleTitle |
Functional interaction between DNA-PK and c-Abl in response to DNA damage.
|
pubmed:affiliation |
Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|